DTA Releases & Statements

DTA Participates in the Frontiers Health Summit

October 22, 2017

Digital Therapeutic Alliance member company leaders Pierre Leurent, CEO, Voluntis, Anand Iyer, Chief Strategy Officer, WellDoc, and Vincent Hennemand, VP of Strategy, Corporate & BD, Akili Interactive, will present at the Frontiers Health Summit on November 17 in Berlin, Germany.

Session — Software as a drug: the dawn of Digital Therapies [Keynote and Panel]
Date — Friday, November 17, 2017¬† 2:15pm – 3:15pm
Description — More than 150 companies are already working on digital therapeutics, and an increasing number of these are starting to show significant clinical evidence. In addition, several pharma companies have started investing in digital therapeutics companies, and are partnering to distribute digital therapeutics through their sales channels. This is a strong indication that digital therapeutics will be the “3rd wave of medicine”. Our panel will discuss the resulting industry transformation, the opportunities for healthcare providers and the pharma industry, and what efforts are underway to define new protocols of care and measures of clinical effectiveness.

For more information about the conference, visit www.frontiershealth.co.


Copyright © 2024 Digital Therapeutics Alliance™